Albany Molecular Research Inc (AMRI) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
21 CORPORATE CIRCLE ALBANY, NY 12203-5154 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8731 - Commercial Physical and Biological Research (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 35,193 | 52,000 | 44,756 | 30,675 | 44,193 | 49,343 | |||
| Cash and cash equivalent | 35,193 | 52,000 | 44,756 | 30,675 | 44,193 | 49,343 | |||
| Restricted cash and investments | 243 | 236 | 242 | 713 | 3,000 | 2,966 | |||
| Receivables | 142,648 | 146,821 | 128,682 | 102,038 | 104,191 | 115,846 | |||
| Inventory, net of allowances, customer advances and progress billings | 174,043 | 167,111 | 201,901 | 93,174 | 94,080 | 89,231 | |||
| Inventory | 174,043 | 167,111 | 201,901 | 93,174 | 94,080 | 89,231 | |||
| Other undisclosed current assets | 33,023 | 26,743 | 28,667 | 30,053 | 28,547 | 22,859 | |||
| Total current assets: | 385,150 | 392,911 | 404,248 | 256,653 | 274,011 | 280,245 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 360,282 | 364,806 | 376,121 | 222,011 | 216,902 | 209,508 | |||
| Long-term investments and receivables | 956 | 956 | 956 | ||||||
| Long-term investments | 956 | 956 | 956 | ||||||
| Intangible assets, net (including goodwill) | 395,048 | 396,430 | 421,022 | 287,737 | 293,608 | 289,675 | |||
| Goodwill | 230,886 | 231,256 | 241,402 | 170,702 | 172,882 | 169,471 | |||
| Intangible assets, net (excluding goodwill) | 164,162 | 165,174 | 179,620 | 117,035 | 120,726 | 120,204 | |||
| Derivative instruments and hedges | 18,535 | 51,003 | 47,436 | 37,316 | 42,199 | 76,393 | |||
| Other noncurrent assets | 3,991 | 3,994 | 5,417 | 2,789 | 3,389 | 3,404 | |||
| Other undisclosed noncurrent assets | 523 | 504 | 2,883 | 3,148 | 5,386 | ||||
| Total noncurrent assets: | 778,379 | 816,737 | 853,835 | 549,853 | 560,202 | 585,322 | |||
| TOTAL ASSETS: | 1,163,529 | 1,209,648 | 1,258,083 | 806,506 | 834,213 | 865,567 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 108,894 | 111,147 | 127,378 | 72,479 | 73,650 | 60,890 | |||
| Taxes payable | 3,627 | 2,826 | 4,162 | ||||||
| Employee-related liabilities | 769 | 11,743 | 380 | 436 | 571 | 7,897 | |||
| Other undisclosed accounts payable and accrued liabilities | 104,498 | 96,578 | 122,836 | 72,043 | 73,079 | 52,993 | |||
| Debt | 34,206 | 36,432 | 35,841 | 13,082 | 13,843 | 15,591 | |||
| Derivative instruments and hedges, liabilities | 6,401 | ||||||||
| Deferred revenue and credits | 19,516 | 13,370 | 14,782 | 10,317 | 13,534 | 14,718 | |||
| Other undisclosed current liabilities | 4,396 | 14,569 | 4,542 | 436 | 571 | 7,897 | |||
| Total current liabilities: | 167,012 | 175,518 | 182,543 | 102,715 | 101,598 | 99,096 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 607,246 | 604,476 | 606,112 | 370,798 | 373,725 | 373,692 | |||
| Long-term debt, excluding current maturities | 607,246 | 604,476 | 606,112 | 370,798 | 373,725 | 373,692 | |||
| Liabilities, other than long-term debt | 92,472 | 130,672 | 131,430 | 70,061 | 54,843 | 89,151 | |||
| Accounts payable and accrued liabilities | 3,894 | 3,769 | 2,101 | 2,101 | 2,956 | 2,956 | |||
| Deferred tax liabilities, net | 36,505 | 40,058 | 45,287 | 20,166 | |||||
| Liability, pension and other postretirement and postemployment benefits | 17,993 | 18,615 | 19,853 | 6,627 | 6,700 | 6,909 | |||
| Other liabilities | 15,545 | 17,227 | 16,753 | 3,851 | 2,988 | 2,893 | |||
| Derivative instruments and hedges, liabilities | 18,535 | 51,003 | 47,436 | 37,316 | 42,199 | 76,393 | |||
| Other undisclosed noncurrent liabilities | 17,129 | 16,405 | |||||||
| Total noncurrent liabilities: | 699,718 | 735,148 | 737,542 | 440,859 | 445,697 | 479,248 | |||
| Total liabilities: | 866,730 | 910,666 | 920,085 | 543,574 | 547,295 | 578,344 | |||
| Equity | |||||||||
| Equity, attributable to parent | 296,799 | 298,982 | 337,998 | 262,932 | 286,918 | 287,223 | |||
| Common stock | 486 | 485 | 485 | 413 | 413 | 411 | |||
| Treasury stock, value | (71,312) | (69,429) | (69,297) | (69,225) | (69,169) | (68,455) | |||
| Additional paid in capital | 403,482 | 400,496 | 398,294 | 303,886 | 300,902 | 296,337 | |||
| Accumulated other comprehensive loss | (32,325) | (39,730) | (14,055) | (18,138) | (12,492) | (18,401) | |||
| Retained earnings (accumulated deficit) | (3,532) | 7,160 | 22,571 | 45,996 | 67,264 | 77,331 | |||
| Total equity: | 296,799 | 298,982 | 337,998 | 262,932 | 286,918 | 287,223 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,163,529 | 1,209,648 | 1,258,083 | 806,506 | 834,213 | 865,567 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 163,822 | 191,322 | 152,738 | 120,810 | 105,579 | 126,412 | ||
| Cost of revenue | (124,937) | (156,744) | (126,453) | (82,740) | (81,963) | (92,516) | ||
| Cost of product and service sold | (122,778) | (152,586) | (123,486) | (82,214) | (79,363) | (92,516) | ||
| Gross profit: | 38,885 | 34,578 | 26,285 | 38,070 | 23,616 | 33,896 | ||
| Operating expenses | (36,804) | (39,990) | (41,946) | (31,604) | (27,768) | (8,375) | ||
| Other undisclosed operating loss | (19,279) | |||||||
| Operating income (loss): | 2,081 | (5,412) | (15,661) | 6,466 | (4,152) | 6,242 | ||
| Nonoperating income (expense) | (793) | 5,930 | (549) | (5,661) | (997) | 333 | ||
| Other nonoperating income (expense) | (793) | 5,930 | (549) | (5,661) | (997) | |||
| Interest and debt expense | (12,830) | (13,009) | (12,714) | (7,064) | (7,136) | (6,820) | ||
| Loss from continuing operations before income taxes: | (11,542) | (12,491) | (28,924) | (6,259) | (12,285) | (245) | ||
| Income tax expense (benefit) | 850 | (2,920) | 5,499 | (15,008) | 2,218 | 2,030 | ||
| Income (loss) from continuing operations: | (10,692) | (15,411) | (23,425) | (21,267) | (10,067) | 1,785 | ||
| Income (loss) before gain (loss) on sale of properties: | (10,692) | (15,411) | (23,425) | (21,267) | (10,067) | 1,785 | ||
| Net income (loss) available to common stockholders, diluted: | (10,692) | (15,411) | (23,425) | (21,267) | (10,067) | 1,785 | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (10,692) | (15,411) | (23,425) | (21,267) | (10,067) | 1,785 | ||
| Other comprehensive income (loss) | 7,405 | (25,675) | (185) | (177) | 5,909 | (4,315) | ||
| Comprehensive loss: | (3,287) | (41,086) | (23,610) | (21,444) | (4,158) | (2,530) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 4,268 | (5,469) | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (3,287) | (41,086) | (19,342) | (26,913) | (4,158) | (2,530) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.